Pages that link to "Q24323234"
Jump to navigation
Jump to search
The following pages link to Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway (Q24323234):
Displaying 50 items.
- Apolipoprotein B (Q648343) (← links)
- Apolipoprotein C1 (Q1977297) (← links)
- Apolipoprotein C2 (Q3445743) (← links)
- apolipoprotein C3 (Q4068038) (← links)
- APOB (Q14890615) (← links)
- APOC1 (Q14904550) (← links)
- APOC3 (Q14910515) (← links)
- APOC2 (Q14916272) (← links)
- Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus (Q21090530) (← links)
- APOE/C1/C4/C2 gene cluster genotypes, haplotypes and lipid levels in prospective coronary heart disease risk among UK healthy men (Q24614472) (← links)
- Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins (Q24651503) (← links)
- Conformational studies of the N-terminal lipid-associating domain of human apolipoprotein C-I by CD and 1H NMR spectroscopy (Q24673369) (← links)
- (Q28240856) (← links)
- Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions (Q28252652) (← links)
- Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia (Q28271254) (← links)
- Increased response to cholesterol feeding in apolipoprotein C1-deficient mice (Q28587768) (← links)
- Modulation of apolipoprotein E-mediated plasma clearance and cell uptake of emulsion particles by cholesteryl ester (Q32051266) (← links)
- Identifying blood biomarkers and physiological processes that distinguish humans with superior performance under psychological stress (Q33519546) (← links)
- APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians (Q33741245) (← links)
- Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes (Q33962626) (← links)
- Complexities of plasma apolipoprotein C-III metabolism (Q34172178) (← links)
- Apolipoproteins in the brain: implications for neurological and psychiatric disorders (Q34680878) (← links)
- Biochemical and functional characterization of charge-defined subfractions of high-density lipoprotein from normal adults (Q35028691) (← links)
- Diabetic dyslipidaemia: from basic research to clinical practice. (Q35139885) (← links)
- Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype (Q35157797) (← links)
- Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles (Q35608640) (← links)
- Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease (Q35628166) (← links)
- Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease (Q35771163) (← links)
- Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease (Q35915137) (← links)
- Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease (Q36366340) (← links)
- Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation (Q36376727) (← links)
- Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: the Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan (Q36527075) (← links)
- Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III (Q36900694) (← links)
- Changes in helical content or net charge of apolipoprotein C-I alter its affinity for lipid/water interfaces (Q36920606) (← links)
- WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects (Q36930204) (← links)
- Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice (Q37202057) (← links)
- ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans (Q37222426) (← links)
- Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma. (Q37299858) (← links)
- Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism. (Q37311103) (← links)
- Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome. (Q37326019) (← links)
- Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets (Q37333795) (← links)
- Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl (Q37358494) (← links)
- In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway (Q37361432) (← links)
- Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E (Q37368158) (← links)
- Managing diabetic dyslipidemia: beyond statin therapy (Q37385184) (← links)
- Development of Antisense Drugs for Dyslipidemia (Q37387192) (← links)
- Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction (Q37389319) (← links)
- Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver (Q37444625) (← links)
- Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph (Q37727877) (← links)
- Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights (Q38543425) (← links)